FI933656L - 2,4-diaminokinazolinderivat, som foerstaerker antitumoeraktivitet - Google Patents

2,4-diaminokinazolinderivat, som foerstaerker antitumoeraktivitet Download PDF

Info

Publication number
FI933656L
FI933656L FI933656A FI933656A FI933656L FI 933656 L FI933656 L FI 933656L FI 933656 A FI933656 A FI 933656A FI 933656 A FI933656 A FI 933656A FI 933656 L FI933656 L FI 933656L
Authority
FI
Finland
Prior art keywords
foerstaerker
diaminoquinazolinde
som
derivatives
tumor activities
Prior art date
Application number
FI933656A
Other languages
English (en)
Finnish (fi)
Other versions
FI933656A7 (fi
FI933656A0 (fi
Inventor
Jotham W Coe
Anton F J Fliri
Takushi Kaneko
Eric R Larson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI933656A7 publication Critical patent/FI933656A7/fi
Publication of FI933656A0 publication Critical patent/FI933656A0/fi
Publication of FI933656L publication Critical patent/FI933656L/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI933656A 1991-02-20 1992-01-08 2,4-diaminokinazolinderivat, som foerstaerker antitumoeraktivitet FI933656L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65792291A 1991-02-20 1991-02-20
PCT/US1992/000028 WO1992014716A1 (en) 1991-02-20 1992-01-08 2,4-diaminoquinazolines derivatives for enhancing antitumor activity

Publications (3)

Publication Number Publication Date
FI933656A7 FI933656A7 (fi) 1993-08-19
FI933656A0 FI933656A0 (fi) 1993-08-19
FI933656L true FI933656L (fi) 1993-08-19

Family

ID=24639196

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933656A FI933656L (fi) 1991-02-20 1992-01-08 2,4-diaminokinazolinderivat, som foerstaerker antitumoeraktivitet

Country Status (23)

Country Link
EP (1) EP0572437B1 (da)
JP (1) JPH06500117A (da)
KR (1) KR930703270A (da)
CN (1) CN1064271A (da)
AT (1) ATE121735T1 (da)
AU (1) AU655798B2 (da)
BR (1) BR9205645A (da)
CA (1) CA2101542A1 (da)
CZ (1) CZ387292A3 (da)
DE (2) DE69202243T2 (da)
DK (1) DK0572437T3 (da)
ES (1) ES2071484T3 (da)
FI (1) FI933656L (da)
HU (1) HUT64755A (da)
IE (1) IE920522A1 (da)
IL (1) IL100942A0 (da)
MX (1) MX9200675A (da)
NO (1) NO932954D0 (da)
NZ (1) NZ241627A (da)
PT (1) PT100132A (da)
WO (1) WO1992014716A1 (da)
YU (1) YU17092A (da)
ZA (1) ZA921911B (da)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661533B2 (en) * 1992-01-20 1995-07-27 Astrazeneca Ab Quinazoline derivatives
ES2049659B1 (es) * 1992-10-08 1994-10-16 Ici Plc Una composicion farmaceutica a base de derivados de quinazolina con actividad anti-cancerigena.
GB9323290D0 (en) * 1992-12-10 1994-01-05 Zeneca Ltd Quinazoline derivatives
GB9314893D0 (en) * 1993-07-19 1993-09-01 Zeneca Ltd Quinazoline derivatives
IL112248A0 (en) 1994-01-25 1995-03-30 Warner Lambert Co Tricyclic heteroaromatic compounds and pharmaceutical compositions containing them
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
DE4429026C2 (de) * 1994-08-16 1995-11-16 Mueller Wolfgang Inlay-Entfernungsinstrumentarium für Totalendoprothese
GB9424233D0 (en) * 1994-11-30 1995-01-18 Zeneca Ltd Quinazoline derivatives
GB9508535D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivative
GB9508565D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quiazoline derivative
GB9508538D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
GB9508537D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
EP0824525B1 (en) * 1995-04-27 2001-06-13 AstraZeneca AB Quinazoline derivatives
WO1997020822A1 (en) * 1995-12-01 1997-06-12 Novartis Ag Quinazolin-2,4-diazirines as npy receptor antagonist
GB9624482D0 (en) * 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
CA2242425C (en) 1996-02-13 2006-07-18 Zeneca Limited Quinazoline derivatives as vegf inhibitors
GB9603095D0 (en) 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
GB9603097D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline compounds
NZ331191A (en) 1996-03-05 2000-03-27 Zeneca Ltd 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof
GB9607729D0 (en) * 1996-04-13 1996-06-19 Zeneca Ltd Quinazoline derivatives
GB9707800D0 (en) 1996-05-06 1997-06-04 Zeneca Ltd Chemical compounds
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
PT1244647E (pt) 1999-11-05 2006-10-31 Astrazeneca Ab Derivados de quinazolina como inibidores de vegf
AU2001240150A1 (en) * 2000-03-13 2001-09-24 Chemrx Advanced Technologies, Inc. Quinazoline synthesis
IL151626A0 (en) 2000-04-07 2003-04-10 Astrazeneca Ab Quinazoline compounds
WO2003055866A1 (en) * 2001-12-21 2003-07-10 Bayer Pharmaceuticals Corporation Quinazoline and quinoline derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
CA2531327A1 (en) 2003-07-03 2005-01-13 Myriad Genetics, Inc. Compounds and therapeutical use thereof
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
JP2007269629A (ja) * 2004-06-21 2007-10-18 Astellas Pharma Inc キナゾリン誘導体
WO2006014420A1 (en) * 2004-07-06 2006-02-09 Angion Biomedica Corporation Quinazoline modulators of hepatocyte growth factor / c-met activity for the treatment of cancer
CA2592900A1 (en) * 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
AU2006204052A1 (en) * 2005-01-03 2006-07-13 Cytovia, Inc. Method of treating brain cancer
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
JP2009518359A (ja) * 2005-12-07 2009-05-07 ノイロサーチ アクティーゼルスカブ 新規なキナゾリン−２，４−ジアミン誘導体及び小コンダクタンスカルシウム依存性カリウムチャネルの調節剤としてのそれらの使用
CN101100466B (zh) 2006-07-05 2013-12-25 天津和美生物技术有限公司 不可逆蛋白质酪氨酸磷酰化酶抑制剂及其制备和应用
US20090004185A1 (en) * 2007-01-11 2009-01-01 Wyeth Amino-substituted quinazoline derivatives as inhibitors of beta-catenin/tcf-4 pathway and cancer treatment agents
CA2691932A1 (en) * 2007-06-27 2008-12-31 Summit Corporation Plc Use of compounds for preparing anti-tuberculosis agents
JP2013530942A (ja) 2010-05-07 2013-08-01 カリフォルニア・インスティチュート・オブ・テクノロジー 移行型小胞体ａｔｐアーゼの阻害のための方法および組成物
US11318137B2 (en) * 2017-05-17 2022-05-03 Vanderbilt University Quinazoline compounds as modulators of Ras signaling

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3635979A (en) * 1969-09-29 1972-01-18 Pfizer Certain 6- and/or 7-alkoxy-substituted-2 4-bis(disubstituted amino) quinazolines
AU610328B2 (en) * 1987-12-03 1991-05-16 Smithkline Beckman Intercredit B.V. 2,4- diaminoquinazoline derivatives
IL88507A (en) * 1987-12-03 1993-02-21 Smithkline Beckman Intercredit 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
ZA921911B (en) 1993-08-19
AU655798B2 (en) 1995-01-12
CA2101542A1 (en) 1992-08-21
HU9302384D0 (en) 1993-11-29
KR930703270A (ko) 1993-11-29
BR9205645A (pt) 1994-06-07
NO932954L (no) 1993-08-19
NO932954D0 (no) 1993-08-19
JPH06500117A (ja) 1994-01-06
FI933656A7 (fi) 1993-08-19
FI933656A0 (fi) 1993-08-19
AU1184892A (en) 1992-09-15
WO1992014716A1 (en) 1992-09-03
YU17092A (sh) 1994-12-28
PT100132A (pt) 1993-05-31
DE69202243D1 (de) 1995-06-01
CN1064271A (zh) 1992-09-09
IL100942A0 (en) 1992-11-15
IE920522A1 (en) 1992-08-26
DE9290018U1 (de) 1993-10-14
HUT64755A (en) 1994-02-28
NZ241627A (en) 1993-06-25
MX9200675A (es) 1992-08-01
EP0572437B1 (en) 1995-04-26
CZ387292A3 (en) 1994-04-13
DE69202243T2 (de) 1995-08-31
DK0572437T3 (da) 1995-07-03
ES2071484T3 (es) 1995-06-16
ATE121735T1 (de) 1995-05-15
EP0572437A1 (en) 1993-12-08

Similar Documents

Publication Publication Date Title
MX9205145A (es) Nuevos derivados heterociclicos.
FI922222A7 (fi) Kopplingsanordning, som foermaor laosa spinalosteosyntesfaestanordningar
FI925615L (fi) Stabiliserade farmaceutiska kompositioner, som innehaoller en HMG-CoA-reduktas-inhibitorfoerening
FI925735L (fi) Polymerer och oligomerer av gallsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
NL300250I2 (nl) Chinuclidinederivaten.
FI932961L (fi) Metallocener med arylsubsituerade indenylderivat som ligander, foerfarande foer framstaellning av dessa och anvaendning av dessa som katalysatorer
FI933656A7 (fi) 2,4-diaminokinatsoliinijohdannaiset, jotka tehostavat kasvaintenvastai sta aktiivisuutta
FI921182A0 (fi) Velangummi som snabbt hydratiseras.
NL300035I1 (nl) Gesubstitueerde thiahzolidinedionderivaten.
FI923281L (fi) Foerbaettrade desinfektionsloesningar, som innehaoller vaeteperoxid
FI925926L (fi) Sammansaettning som innehaoller hydrerade sackarider med laog kariesframkallande effekt, foerfarande foer framstaellning av dessa och tillaempningen av denna sammansaettning
FI945662A0 (fi) Roerformad stomme, i synnerhet som hylselement och med hylselement foersedd stomme
FI931707L (fi) 1,2,4-oxadiazolyl-fenoxialkylisoxazoler och deras anvaendning som virusmotarbetande aemnen
FI922235L (fi) Foerfarande foer framstaellning av 3-aminopyridazinderivat, som verkar paodet centrala nervsystemet
FI920271L (fi) Polyamintioler som straolningsskyddande aemnen.
FI910572A7 (fi) Regnmaetare med anordning som paovisar tilltaeppning.
FI920735A7 (fi) Vattenhaltiga polymerdispersioner som innehaoller organiska foereningar med karbonat- och karbonylgrupper, liksom daermed framstaellda maolnings-och ytbehandlingssystem
FI920192L (fi) Substituerade 1,2,3,4-tetrahydro -cyklopent/b/indoler, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoler och motsvarande foereningar, mellanprodukter och foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
FI923367L (fi) Molekyler med antikroppkombinations- staellen som katalyserar hydrolysreaktioner.
FI914453A7 (fi) Foerfarande foer kompressering av en videobild, som kodats digitaliskt
FI920394L (fi) 3-kinuklidinderivat.
FI932654L (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
FI925875L (fi) Foerfarande foer framstaellning av nya som inhibitorer av proteolytiska enzymer anvaendbara 2-sackarinylmetyl- och 4,5,6,7-tetrahydro-2-sackarinylmetylfosfater, -fosfonater och -fosfinater
FI923555A0 (fi) Foerfarande foer framstaellning av mattor som bestaor av minst tvao med varandra bundna skikt.
FI931794L (fi) Monokvaternaera 2,16-bispiperidinylandrostanderivat

Legal Events

Date Code Title Description
FD Application lapsed